NCT00948922 · OUTCOME

Percentage of Participants With Acute or Chronic Graft-versus-host Disease (GVHD) Following Transplant

Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma · Source last updated 2019-09-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: percentage of participants
Interval / dispersion: Not reported
Time frame: End of 2 year, post transplant follow-up

What was measured

Percentage of participants with Acute or Chronic GVHD following transplant

Analysis population: Allogenic Stem Cell Transplant patients only. Autologous patients do not suffer from GVHD.

Groups in this outcome

A: Allogenic Stem Cell Transplant

Allogenic Stem Cell Transplant: Fludarabine + Melphalan + Bortezomib followed by Allogenic Rescue

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
A: Allogenic Stem Cell Transplant	26

Reported measurements

Source class 1

Values in percentage of participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
A: Allogenic Stem Cell Transplant	34	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
34

denoms

counts
group Id
OG000
value
26
units
Participants

description

Percentage of participants with Acute or Chronic GVHD following transplant

groups

description
Allogenic Stem Cell Transplant: Fludarabine + Melphalan + Bortezomib followed by Allogenic Rescue
id
OG000
title
A: Allogenic Stem Cell Transplant

param Type

NUMBER

population Description

Allogenic Stem Cell Transplant patients only. Autologous patients do not suffer from GVHD.

reporting Status

POSTED

time Frame

End of 2 year, post transplant follow-up

title

Percentage of Participants With Acute or Chronic Graft-versus-host Disease (GVHD) Following Transplant

type

OTHER_PRE_SPECIFIED

unit Of Measure

percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice